She is interested in disorders of insulin resistance that have an impact on the reproductive axis and cardiometabolic health
GLP-1 RAs bypass genetic defects in the leptin-melanocortin system, promote weight loss, and improve metabolic function through the coordinated regulation of blood glucose and appetite [64,65] [Figure 2]
These properties make GLP1-S a key research tool in models of insulin resistance, beta-cell function, and type 2 diabetes[5]
Moreover, safety risks are emerging, particularly when compounded formulations include substances not found in FDA-approved versions 1
All of these medications regulate appetite, but they differ in FDA indication, hormonal pathways, and metabolic potency
Effects of the once-daily human GLP-1 analogue liraglutide on appetite and energy intake in type 2 diabetes